Stay updated on Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T01:54:28.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” in some content.
    Difference
    1%
    Check dated 2026-10-25T01:52:48.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T01:40:52.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:08:44.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, blocking access to the study record details and showing an access-denied message instead.
    Difference
    20%
    Check dated 2026-09-20T00:54:52.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page updated the revision label from v3.6.5 to v3.6.6, indicating a newer version of the study documents; this appears to be an administrative update rather than a substantive change to study information.
    Difference
    0.1%
    Check dated 2026-08-29T19:53:54.000Z thumbnail image

Stay in the know with updates to Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.